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procedures. The search time of CABG was significantly shorter in the fusion
group of images in the control group (16.04 min±13.2 min vs 6.4 min±4.7 min,
p=0.002 ) , as well as procedure time (31.5 min±15.2 min vs 19.4 min± 6.8 min,
p = 0.007 ) , fluoroscopy time (14.76 min±8.3 min vs 9.3 min±4.2 min, p = 0.04),
Air KERMA (822.9 mGy±475.5 mGy vs 569.1 mGy±242.4 mGy , p = 0.01) and
amount of iodinated contrast (121 cc ± 43.5 cc vs 88.2 cc±30.8 cc, p = 0.01).
3D reconstruction of CABG from CT with real-time fusion on coronary angio-
graphy images may shorten the search time of CABG, procedure time, X-Ray
exposure and the use of iodinated contrast compared to standard coronary
angiography for diagnostic purposes in patients with CABG. 
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Purposes: to assess myocardial viability by speckle-tracking echocardiog-
raphy (STE) in patients (pts) with coronary artery disease (CAD) and type
2 diabetes mellitus (DM2).
Methods: We examined 65 pts with CAD (45 males, age 60.5±4.7 years),
among them 20 pts with T2DM. Baseline characteristics of pts included his-
tory of CAD (7.2±2.3 years) and DM2 (4.7±0.5). The presence and extent of
CA lesion were performed using coronary angiography. Consecutive percuta-
neous coronary intervention (PCI) was performed to 32 pts, including 10 pts
with DM2 (1st group (gr)) and 22 pts without concomitant DM2 (2nd gr). All
pts underwent STE before and one year after PCI.
Results: Coronary angiography demonstrated that among pts with CAD
and DM2 in 25% cases (n=5) registered atherosclerotic lesion of one CA and
in 45% (n=9) lesion of two or three CA compared with the 40% (n=18) and
20% (n=9) respectively in pts with CAD without concomitant DM2 (p<0.05).
Total of 312 LV myocardial segments were analyzed by STE. The number of
abnormal segments that recovered function in the 1st gr was significantly
lower than in the 2nd gr (27% (n=24) vs 35% (n=79), p<0.05). Assessing LV
functional recovery one year after revascularization pts of the 1st gr demon-
strated lower end-systolic longitudinal (LongS,%), radial (RadS,%) and cir-
cumferential (CircS,%) strains (LongS – 9.3±6.2 vs –12.7±6.7, p=0.033; RadS
16.3±10.8 vs 22.5±11.7, p=0.026; CircS – 8.2±7.9 vs –12.3±8.5, p=0.043)
than in the 2nd gr (LongS – 11.8±7.2 vs –14.3±7.3, p=0.015; RadS 19.8±12.4
vs 23.5±11.3, p=0.025; CircS – 9.8±8.7 vs –12.5±8.1, p=0.021). 
Conclusions: pts with CAD and DM2 had lesser degree of LV functional
recovery one year after revascularization compared to those without DM2 that
can be explained by peculiarities of CA atherosclerotic lesion. Assessments of
LV myocardial viability using STE is recommended for patients selection
before revascularization and further follow up. 
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Background: After myocardial infarction, patients have a very heteroge-
neous risk of cardiovascular death and/or reinfarction. Furthermore, no genetic
approach score, as part of secondary prevention, was found in the literature.
Aim: This is a prospective longitudinal study (mean follow up of
9.6 years) including 146 patients, hospitalized between August 1997 and
August 2004 for a myocardial infarction (MI) who survived the 30 first day
after the MI. Depending on the composite event cardiovascular death and/or
myocardial infarction, the genetic score was derived from 43 single nucleotide
polymorphisms (SNP) belonging to 26 different genes. In the same study 3
clinical and biological scores were calculated (European SCORE, Hard coro-
nary heart disease and coronary heart death score of Framingham scores). A
multivariate analysis using logistic regression was used. 
Results: Mortality at 10 years was 12.3% with a median time of 5.2±
4.8 years.
The incidence of the composite event cardiovascular death and/or myo-
cardial infarction was 23.4% with a mean of 8.4±4.1 years.The genetic score
predicting the composite event cardiovascular death and/or myocardial infarc-
tion is an equation that included age (OR=1.04, 95% CI: 0.98, 1.1) and the
following polymorphisms eNOS894 (OR=1.87, 95%: 0.64, 5.43);
rs2781665AT arginase (OR = 1.63, 95% CI: 0.69, 3.85); 45TG adiponectin
(OR=1.62, 95% CI: 0.65,4.02); eNOS4a4b (OR=1.29, 95% CI: 0.53, 3.14) and
MTP (OR=0.78, 95% CI: 0.35,1.74). The clinical and biological scores were
all correlated with the long-term corrsponding predicted. Correction factors
were calculated for each score. The genetic score had the best reliability with
a Sensitivity = 73.3%, a Specificity = 61.3%, a predictive positive value
=31.11%, a predictive negative value = 90.74%. 
Conclusion: It seems that using a genetic score provides a good prediction
of event cardiovascular death and/or myocardial infarction at long term. A
validation of our genetic score and a combined clinical-genetic approach to a
large population remains our future hope (table next page).
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